Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (31)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schlack, W.
Right arrow Articles by Thamer, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schlack, W.
Right arrow Articles by Thamer, V.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, Vol 79, Issue 1 88-96, Copyright © 1997 by The Board of Management and Trustees of the British Journal of Anaesthesia


LABORATORY INVESTIGATIONS

Halothane reduces reperfusion injury after regional ischaemia in the rabbit heart in vivo

W. Schlack, B. Preckel, H. Barthel, D. Obal and V. Thamer
Institut fur Klinische Anaesthesiologie and Physiologisches Institut I, Heinrich-Heine-Universitat Dusseldorf, Dusseldorf, Germany

In addition to having anti-ischaemic effects, halothane can protect isolated rat hearts and isolated cardiomyocytes against reperfusion injury of the "oxygen paradox" type. The aim of this study was to investigate if halothane can also protect against myocardial reperfusion injury in vivo. Twenty-two rabbits anaesthetized with alpha- chloralose underwent 30 min of occlusion of a major coronary artery and 2 h of subsequent reperfusion. Seven animals received 1 MAC of halothane for the first 15 min of reperfusion (halothane group), and eight animals served as untreated controls (controls group). In seven additional animals, the haemodynamic effects of halothane were antagonized by an i.v. infusion of noradrenaline (halothane- noradrenaline group). We measured cardiac output (CO) by an ultrasonic flow probe around the ascending aorta, left ventricular pressure (LVP) by a tip manometer and infarct size by triphenyltetrazolium staining. Baseline LVP was mean 92 (SEM 4) mm Hg and CO was 289 (16) ml min-1. During coronary occlusion, LVP was reduced to 86 (4)% of baseline and CO to 84 (4)% (similar in all groups). During halothane administration at reperfusion, LVP declined further to 55 (6)% of baseline and CO to 66 (9)% (P < 0.05 halothane group vs control group). Noradrenaline prevented the reduction in LVP (halothane-noradrenaline group 87 (5)% of baseline, control group 84 (6)% and reduction in CO (halothane- noradrenaline group 89 (5)%, control group 83 (6)%. Infarct size was 49 (6)% of the area at risk in controls and was reduced markedly by administration of halothane to 32 (3)% in the halothane group (P < 0.05) and to 30 (3)% in the halothane-noradrenaline group (P < 0.05). Treatment with halothane during the early reperfusion period after myocardial ischaemia protected the myocardium against infarction in vivo, independent of the haemodynamic effect of halothane.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Neurosci.Home page
J. H.-C. Lin, N. Lou, N. Kang, T. Takano, F. Hu, X. Han, Q. Xu, D. Lovatt, A. Torres, K. Willecke, et al.
A Central Role of Connexin 43 in Hypoxic Preconditioning
J. Neurosci., January 16, 2008; 28(3): 681 - 695.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. Rodriguez-Sinovas, D. Garcia-Dorado, M. Ruiz-Meana, and J. Soler-Soler
Enhanced effect of gap junction uncouplers on macroscopic electrical properties of reperfused myocardium
J. Physiol., August 15, 2004; 559(1): 245 - 257.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Garcia-Dorado, A. Rodriguez-Sinovas, and M. Ruiz-Meana
Gap junction-mediated spread of cell injury and death during myocardial ischemia-reperfusion
Cardiovasc Res, February 15, 2004; 61(3): 386 - 401.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Tonkovic-Capin, G. J. Gross, Z. J. Bosnjak, J. S. Tweddell, C. M. Fitzpatrick, and J. E. Baker
Delayed cardioprotection by isoflurane: role of KATP channels
Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H61 - H68.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
D. Ebel, B. Preckel, A. You, J. Mullenheim, W. Schlack, and V. Thamer
Cardioprotection by sevoflurane against reperfusion injury after cardioplegic arrest in the rat is independent of three types of cardioplegia
Br. J. Anaesth., June 1, 2002; 88(6): 828 - 835.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
B. Preckel, W. Schlack, T. Heibel, and H. Rutten
Xenon produces minimal haemodynamic effects in rabbits with chronically compromised left ventricular function
Br. J. Anaesth., February 1, 2002; 88(2): 264 - 269.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
D. Obal, B. Preckel, H. Scharbatke, J. Mullenheim, F. Hoterkes, V. Thamer, and W. Schlack
One MAC of sevoflurane provides protection against reperfusion injury in the rat heart in vivo
Br. J. Anaesth., December 1, 2001; 87(6): 905 - 911.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
B. Preckel, J. Mullenheim, A. Moloschavij, V. Thamer, and W. Schlack
Xenon Administration During Early Reperfusion Reduces Infarct Size After Regional Ischemia in the Rabbit Heart In Vivo
Anesth. Analg., December 1, 2000; 91(6): 1327 - 1332.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.